• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Check-Cap Ltd.

    5/23/25 5:00:02 PM ET
    $CHEK
    Medical Electronics
    Health Care
    Get the next $CHEK alert in real time by email
    6-K 1 ea0243419-6k_check.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

    THE SECURITIES EXCHANGE ACT OF 1934

     

    For May, 2025

     

    Commission File No. 001-36848

     

    Check-Cap Ltd.

     

    Check-Cap Building

    Abba Hushi Avenue

    P.O. Box 1271

    Isfiya, 30090

    Mount Carmel, Israel

    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES.)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒     Form 40-F ☐

     

     

     

     

     

     

    This Form 6-K is being incorporated by reference into Check-Cap Ltd.’s Registration Statements on Form F-3 (File No. 333-211065, 333-225789 and 333-262401) and Form S-8 (File No. 333-203384, 333-226490 and 333-259666) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

     

    Receipt of Nasdaq Delinquency Notice

     

    On May 21, 2025, Check-Cap Ltd. (the “Company”) received a delinquency letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) relating to the Company’s obligation to file periodic financial reports for continued listing, due to the Company’s failure to file its Annual Report on From 20-F for the year ended December 31, 2024 (“Form 20-F”) with the Securities and Exchange Commission (the “SEC”).

     

    The Letter further stated that the Company has 60 calendar days from the date of the Letter, or July 21, 2025, to submit a plan (the “Plan”) to regain compliance with respect to the delinquent Form 20-F. If Nasdaq accepts the Plan, it may grant an exception of up to 180 calendar days from the due date of the Form 20-F, or November 11, 2025, for the Company to regain compliance. If Nasdaq does not accept the Plan, the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel.

     

    The Company will continue to work diligently with the objective of filing the Form 20-F as soon as practicable and will work diligently to submit the Plan promptly and take the necessary steps to regain compliance as soon as practicable.

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Check-Cap Ltd.
         
    Date: May 23, 2025 By: /s/ David Lontini
        Name:  David Lontini
        Title: Chairman of the Board

     

    2

     

    Get the next $CHEK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHEK

    DatePrice TargetRatingAnalyst
    8/9/2021$4.00 → $3.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $CHEK
    Financials

    Live finance-specific insights

    See more
    • Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders

      Company Has Suspended Calls Since the Second Quarter of 2024 to Avoid Facing the Music for Board's and Management Team's Destruction of 99% of Stock's Value, Costing Shareholders $1 Billion  Conference Call is a Blatant, Self-Serving Reaction by a Management Team Running Scared Following Apollo Capital's Intention to Nominate Six Highly Qualified Directors to MediPharm's Board  Shareholders Deserve Answers From Management About Massive Underperformance, Failed Operational Strategies, Poor Capital Allocation, Outrageous Compensation, and Lack of Transparency Apollo Capital's Nominees Bring Significant Turnaround, M&A, and Operational Experience in Cannabis and Adjacent Industries, and Will Ex

      5/14/25 8:30:00 AM ET
      $CHEK
      Medical Electronics
      Health Care
    • Keystone Dental Group Granted Patent from USPTO for Nexus IOS Solution

      IRVINE, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Osteon Medical, a subsidiary of Keystone Dental Holdings ("Keystone Dental" or the "Company"), today announced the United States Patent and Trademark Office (USPTO) has granted the Company a patent for its innovative Nexus IOS solution. The Nexus iOS Scan Gauge technology allows implant dentists to perform direct full-arch implant scans using an Intraoral Scanner (IOS) with predictable and passive fitting prosthetic outcomes. This technology replaces the traditionally manual impression-taking process through a faster, cost-effective, and accessible workflow. The Nexus iOS Scan Gauge technology is now the only patented elongated body scan

      10/18/23 4:05:00 PM ET
      $CHEK
      Medical Electronics
      Health Care
    • Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement

      Proposed business combination to create a Nasdaq-listed medical device company focused on advancing the commercial execution and market development of Keystone's comprehensive portfolio of implants, arches and other tooth replacement solutions Keystone 2022 revenues exceeded $60 million The combined company will trade on the NASDAQ with the ticker "KSD" Investor conference call and webcast scheduled for 8:30 a.m. ET on Thursday, August 17th IRVINE, Calif. and BURLINGTON, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Keystone Dental Holdings, Inc. ("Keystone Dental") and Check-Cap Ltd. ("Check-Cap" or the "Company") (NASDAQ:CHEK) today announced that they have entered into a definitive Busin

      8/16/23 5:08:47 PM ET
      $CHEK
      Medical Electronics
      Health Care

    $CHEK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $CHEK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SEC Form SC 13D/A filed by Check-Cap Ltd. (Amendment)

      SC 13D/A - Check-Cap Ltd (0001610590) (Subject)

      4/8/24 7:35:32 PM ET
      $CHEK
      Medical Electronics
      Health Care
    • SEC Form SC 13D filed by Check-Cap Ltd.

      SC 13D - Check-Cap Ltd (0001610590) (Subject)

      4/1/24 9:26:38 PM ET
      $CHEK
      Medical Electronics
      Health Care
    • SEC Form SC 13D/A filed by Check-Cap Ltd. (Amendment)

      SC 13D/A - Check-Cap Ltd (0001610590) (Subject)

      12/18/23 6:07:13 AM ET
      $CHEK
      Medical Electronics
      Health Care
    • Check-Cap claims BMO's Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During Wartime

      Check-Cap Ltd. Issues Strong Condemnation of MediPharm Labs Chairman Chris Taves for Fabricated Defamatory Statements Press Releases Taves Times his Attack to Commence 23 Minutes before the Start of Shabbat to Delay the Company from Responding ISFIYA, ISRAEL, June 04, 2025 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ:CHEK) ("Check-Cap" or the "Company"), a clinical-stage medical diagnostics company incorporated in Israel, today publicly condemned MediPharm Labs Corp. (LABS) ("MediPharm Labs") and its Chairman, Chris Taves, Head of Asia for BMO Capital Markets, for disseminating derogatory, false, and misleading statements about Check-Cap during a profoundly sensitive and challenging time

      6/4/25 7:00:00 AM ET
      $CHEK
      Medical Electronics
      Health Care
    • Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders

      Company Has Suspended Calls Since the Second Quarter of 2024 to Avoid Facing the Music for Board's and Management Team's Destruction of 99% of Stock's Value, Costing Shareholders $1 Billion  Conference Call is a Blatant, Self-Serving Reaction by a Management Team Running Scared Following Apollo Capital's Intention to Nominate Six Highly Qualified Directors to MediPharm's Board  Shareholders Deserve Answers From Management About Massive Underperformance, Failed Operational Strategies, Poor Capital Allocation, Outrageous Compensation, and Lack of Transparency Apollo Capital's Nominees Bring Significant Turnaround, M&A, and Operational Experience in Cannabis and Adjacent Industries, and Will Ex

      5/14/25 8:30:00 AM ET
      $CHEK
      Medical Electronics
      Health Care
    • MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders

      TORONTO, May 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX:LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and proxy materials (the "Meeting Materials") for its upcoming Annual and Special Meeting of Shareholders, scheduled for June 16, 2025. The Meeting Materials will be sent to shareholders in the coming days, and are available on the SEDAR+ website at www.sedarplus.ca. MediPharm's Board of Directors (the "Board") recommends that shareholders vote through the GREEN proxy or GREEN voting instruction card in support of the Company's nominees for Board of Dir

      5/13/25 7:31:00 AM ET
      $CHEK
      Medical Electronics
      Health Care

    $CHEK
    Leadership Updates

    Live Leadership Updates

    See more
    • Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting

      Recommends Fellow Shareholders Vote AGAINST Keystone Transaction & the Check-Cap Board Nominees - Further Recommends a Vote FOR the Symetryx Slate of Director Candidates Cites Unrealistic and Aggressive Valuation of Keystone Used to Justify the Merger and Troubling Cash Burn by Check-Cap Board & Management TORONTO, Nov. 28, 2023 /PRNewswire/ - Symetryx, a holder of 5.6% of Check-Cap Ltd. (NASDAQ:CHEK) shares, today issued the following open letter to shareholders. In the letter Symetryx cites, among other items, its serious concerns and reason for voting AGAINST the proposed transaction with Keystone Dental.  Symetryx discusses its concerns around the actions of the Board in its evaluation

      11/28/23 11:56:00 AM ET
      $CHEK
      Medical Electronics
      Health Care
    • Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs

      ISFIYA, Israel, Sept. 1, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ:CHEK), (NASDAQ:CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced the appointment of Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs. Dr. Brenner-Lavie will be responsible for leading the Company's overall clinical strategy and implementation as well as driving the Company's clinical direction, including innovation. "Dr. Brenner-Lavie has a proven track record of clinical strategy dev

      9/1/21 8:30:00 AM ET
      $CHEK
      Medical Electronics
      Health Care

    $CHEK
    SEC Filings

    See more
    • SEC Form 6-K filed by Check-Cap Ltd.

      6-K - Check-Cap Ltd (0001610590) (Filer)

      5/23/25 5:00:02 PM ET
      $CHEK
      Medical Electronics
      Health Care
    • SEC Form NT 20-F filed by Check-Cap Ltd.

      NT 20-F - Check-Cap Ltd (0001610590) (Filer)

      5/1/25 4:15:02 PM ET
      $CHEK
      Medical Electronics
      Health Care
    • SEC Form 6-K filed by Check-Cap Ltd.

      6-K - Check-Cap Ltd (0001610590) (Filer)

      4/15/25 4:15:15 PM ET
      $CHEK
      Medical Electronics
      Health Care

    $CHEK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright & Co. reiterated coverage on Check-Cap with a new price target

      HC Wainwright & Co. reiterated coverage of Check-Cap with a rating of Buy and set a new price target of $3.00 from $4.00 previously

      8/9/21 6:35:25 AM ET
      $CHEK
      Medical Electronics
      Health Care
    • Check-Cap downgraded by Dawson James with a new price target

      Dawson James downgraded Check-Cap from Buy to Neutral and set a new price target of $2.00

      3/17/21 12:12:30 PM ET
      $CHEK
      Medical Electronics
      Health Care
    • HC Wainwright & Co. reiterated coverage on Check-Cap with a new price target

      HC Wainwright & Co. reiterated coverage of Check-Cap with a rating of Buy and set a new price target of $4.00 from $1.50 previously

      3/16/21 6:31:50 AM ET
      $CHEK
      Medical Electronics
      Health Care